Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOLRIAMFETOL vs SOMATROPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOLRIAMFETOL vs SOMATROPIN: Safety Overview

Metric SOLRIAMFETOL SOMATROPIN
Total FAERS Reports 2,135 68,384
Deaths Reported 9 1,350
Death Rate 0.4% 2.0%
Hospitalizations 75 4,957
Average Patient Age 43.2 yrs 18.2 yrs
% Female Patients 71.4% 39.8%
FDA Approval Date Jun 17, 2019 N/A
Manufacturer Axsome Therapeutics, Inc. Genentech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Discontinued